Proton Therapy treatment planning for spine and base of brain of pediatric patient Ashya King.
Proton therapy using the eclipse proton treatment planning system for a prostate.
Varian Eclipse Proton Therapy Treatment Planning for a Spinal case.

As proton therapy becomes more widely available, imaging for the development of proton treatment plans will become more commonplace. However, there are major differences in how treatment is planned for proton therapy compared to traditional radiation therapy. While anatomical imaging is the main focus in radiation therapy, proton therapy requires highly calibrated computed tomography (CT) datasets that are used to directly compute a highly technical treatment plan. 
Weight bearing orthopedic MRI scanner, the G-scan by Esoate.
GE Healthcare's ViosWorks cardiac MRI analysis software.
An example of a Philip's mDixon MRI brain scan.
Philips ScanWise helps technologists set up MRI scanners to improve workflow efficiency.
Siemens Healthineers simultaneous Multi-Slice (SMS) acquires multiple diffusion tensor imaging (DTI) slices simultaneously.

Introduced in the 1980s, magnetic resonance imaging (MRI) has become an integral part of any radiology department. The modality has most often been used for brain and spine scans, but new applications are expanding its capabilities in recent years. Vendors are also working to reduce both scan times and machine size for enhanced productivity. 
Whale's bi-plane mobile C-arm system.

Now more than ever, thanks to healthcare reform, hospitals and clinics are having to find innovative ways to be flexible with their imaging systems. 

Novel technology developed by HeartFlow Inc. significantly reduces the need for invasive procedures to diagnose patients suspected of having coronary artery disease.

The need to repeat even one scan can put you behind schedule, increasing patient wait times and staff overtime. 

The ITN team has just returned from the Healthcare Information and Management Systems Society’s (HIMSS16) annual conference in Las Vegas, where more than 40,000 healthcare IT professionals gathered to learn about and share information on optimizing healthcare outcomes using information technology. 

Pyrexar Medical announced a new distribution partnership with Clinitech Co. Ltd., bringing Pyrexar’s hyperthermia technologies into Cuba, the West Indies, Panama and Venezuela.

April 1, 2016 — Augmenix Inc. announced the publication of the SpaceOAR System U.S. Clinical Trial results of the application technique and impact on prostate intensity modulated radiation therapy (IMRT).

Designed to act as a temporary spacer, the absorbable hydrogel pushes the rectum away from the prostate and reduces rectal radiation injury in men undergoing prostate cancer radiotherapy.

April 1, 2016 — Pyrexar Medical announced the achievement of ISO 13485 Certification and CE re-certification for its line of hyperthermia products for cancer treatment.

ISO 13485 represents the requirements for a comprehensive quality management system for the design and manufacture of medical devices. The ISO standard is also a required compliance to do business in the European Union.

The CE Mark allows Pyrexar to ship medical devices to any of the 27 member states of the EU.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now